Wright M, Garès M, Verdier-Pinard P, Moisand A, Berlion M, Legrand J J, Bizzari J P
C.N.R.S., Laboratoire de Pharmacologie et de Toxicologie Fondamentales, Toulouse, France.
Cancer Chemother Pharmacol. 1991;28(6):434-40. doi: 10.1007/BF00685819.
The action of two epimers of a new vinblastine derivative that differ in their in vivo antitumor activity and their cytotoxicity was studied in vitro in brain microtubule proteins. These two compounds, called S-12363 and S-12362, could not be distinguished from one another or from other active vinca alkaloids by their ability to prevent microtubule assembly. However, they differed strongly both from one another and from vincristine and vinblastine in their ability to induce the formation of tubulin paracrystals and in the stability of the paracrystals following temperature shifts from 0 degree to 37 degrees C and vice versa. The most potent drug, S-12363, induced considerable tubulin aggregation, which was even more pronounced than that observed in the presence of vincristine. Previous results have shown that S-12363, in contrast to vincristine, induces no neurotoxic effects. This observation is in disagreement with a direct relationship between tubulin aggregation and neurotoxicity.
在脑微管蛋白中对一种新长春碱衍生物的两种差向异构体的作用进行了体外研究,这两种差向异构体在体内抗肿瘤活性和细胞毒性方面存在差异。这两种化合物,称为S - 12363和S - 12362,通过它们阻止微管组装的能力,无法彼此区分,也无法与其他活性长春花生物碱区分开来。然而,它们在诱导微管蛋白副晶体形成的能力以及在温度从0摄氏度转变为37摄氏度及反之亦然后副晶体的稳定性方面,彼此之间以及与长春新碱和长春碱都有很大差异。最有效的药物S - 12363诱导了相当程度的微管蛋白聚集,这种聚集比在长春新碱存在下观察到的更为明显。先前的结果表明,与长春新碱不同,S - 12363不会诱导神经毒性作用。这一观察结果与微管蛋白聚集和神经毒性之间的直接关系不一致。